 |
 |

Inappropriate Use of Antibiotics and the Risk for Delayed Admission and Masked Diagnosis of Infectious Diseases
A Lesson From Taiwan
Yung-Ching Liu, MD;
Wen-Kuei Huang, MT;
Tsi-Shu Huang, MS;
Calvin M. Kunin, MD
Arch Intern Med. 2001;161:2366-2370.
ABSTRACT
Background Antibiotic resistance is a serious problem worldwide. It is particularly
alarming in Taiwan and other countries of the Pacific Rim, where antimicrobial
drugs are used excessively.
Objective To determine whether use of antimicrobial drugs before coming to an
emergency department was associated with delayed admission or masked or missed
diagnoses at a large general hospital in Taiwan.
Methods Antimicrobial activity in urine (AAU) was determined in all patients
seen in the emergency department during a 3-month study. A physician, unaware
of the results of the urine tests, reviewed the medical charts of patients
who were admitted to the hospital to determine whether admission was delayed
for at least 7 days or the diagnosis was masked or missed.
Results Of the 1182 patients, 444 were admitted to the hospital. In 220 patients
(49.5%), AAU was detected. There was no significant difference in AAU between
patients with or without an infectious disease (53.0% vs 46.3%, respectively; P = .41). For patients with infection, 34.8% of those with
AAU had a delayed admission, compared with only 21.6% without AAU (relative
risk [RR], 1.61; 95% confidence interval [CI], 1.03-2.52; P = .03). For patients without infection, 36.2% of those with AAU had
a delayed admission compared with 31.1% without AAU (RR, 1.16; 95% CI, 0.81-1.68; P = .64). For patients with infection, 48.7% of those with
AAU had a masked or missed diagnosis, compared with 25.5% without AAU (RR,
1.91; 95% CI, 1.30-2.80; P<.001). For patients
without infection, 27.6% of those with AAU had a masked or missed diagnosis
compared with 14.8% without AAU (RR, 1.87; 95% CI, 1.11-3.17; P = .02).
Conclusion Use of antimicrobial drugs before coming to an emergency department
was associated with a significantly increased risk for delayed and masked
or missed diagnoses of infectious diseases and missed diagnosis of noninfectious
diseases.
INTRODUCTION
INAPPROPRIATE USE of antimicrobial drugs is a serious medical and societal
problem. It fosters the emergence of resistant microorganisms; produces unwarranted
allergic reactions, toxic effects, and expenditures; and can mask the correct
diagnosis and delay appropriate therapy. These problems were well recognized
soon after the antibiotic era began almost 60 years ago1
and have accelerated ever since.2-6
The situation may become worse as managed care compels physicians to spend
less time with patients and perform fewer diagnostic tests, pharmaceutical
companies increase patient expectations by direct advertising to consumers,
and pressures are exerted to permit systemic antibiotics to become available
without prescription in developed countries.7-10
Taiwan is a nation of about 23 million people. It has one of the highest
rates of antibiotic-resistant microorganisms in the world. The extremely high
prevalence of antibiotic-resistant Streptococcus pneumoniae appears to be related to the dissemination of high-level penicillin,
extended-spectrum cephalosporin, and erythromycin-resistant clones
and the selective pressure of antibiotic use.11-13
The Taiwanese now have universal health insurance. This has increased
physician visits, but the average time spent with a patient has increased
from only 5.8 to 7.7 minutes.14 Simple diagnostic
tests are often not performed or are deferred until the patient becomes severely
ill and is referred to a hospital. The reasons for the short visits are complex
and cultural but are partly related to inadequate compensation for office
visits and laboratory tests. Physicians also sell drugs to their patients.
Patients often seek the advice of several physicians and other health care
providers and may be given additional drugs.
Community use of antimicrobial drugs can be readily determined in developed
countries by measuring sales and prescriptions and through surveys of physicians'
prescribing practices. It is much more difficult to measure use in developing
countries, where consumers are often unaware of the drug that was prescribed,
purchased, or injected by a local pharmacist. Physician and pharmacy records
may be unavailable. The task is made even more difficult by the wide range
of available products and mixtures, by adulteration, and by inadequate labeling.
In a previous study, we found that antimicrobial activity could not
be detected in the urine of volunteers who had not recently received antimicrobial
drugs.15 Activity was detected for about 12
to 24 hours after a single oral dose of -lactam antibiotics and erythromycin
and for 48 hours or more after clindamycin, tetracycline, the combination
of trimethoprim and sulfamethoxazole, and ciprofloxacin hydrochloride. Bacillus stearothermophilus produced the largest zones
of inhibition and detected activity for the longest times. In hospitalized
patients receiving multiple drugs, the sensitivity and specificity were 100.0%
and 85.9%, respectively, for B stearothermophilus;
94.9% and 94.9%, respectively, for Streptococcus pyogenes; and 71.8% and 98.7%, respectively, for Escherichia
coli. Thus, detection of antimicrobial activity in the urine (AAU)
appeared to be a good surrogate marker for use of antimicrobial drugs within
12 to 48 hours.
In epidemiological studies, we used a combination of all 3 microorganisms
to obtain the greatest sensitivity and to detect the longest interval after
the last dose.16 We detected AAU in 55.2% of
1182 patients in an emergency department (ED), 25.1% of 203 internal medicine
outpatients, 7.6% of 471 high school students, and 7.4% of 202 people at a
senior citizen center.
In this report, we describe the effect of prior use of antimicrobial
drugs on delaying admission or masking the diagnosis of infectious and noninfectious
diseases among patients seen at the ED of a 1100-bed general hospital in Kaohsiung,
Taiwan's second largest city. The veterans general hospitals in Taiwan provide
free care for veterans and serve as general hospitals for all people in their
communities. Assay of AAU was used as a surrogate marker for recent antibiotic
use, because Taiwanese patients were often unaware of the drug prescribed
by physicians or purchased in drug stores.15-16
The lessons learned from this study may be applicable to emerging events in
the United States and other Western countries.
SUBJECTS AND METHODS
STUDY POPULATION
All patients who came to the ED of the Kaohsiung Veterans General Hospital
during the 3 months from January to April 1997, were asked whether they had
recently received antimicrobial drugs and to submit a urine specimen. The
ED records were reviewed to obtain the initial diagnosis and demographic information
and to determine whether the patient had been admitted to the hospital or
discharged. The study population consisted of patients who came directly to
the ED for care or were referred from the clinic within 3 days and admitted
to the hospital. Patients who were transferred from another medical facility
were not included. One of us (Y.-C.L.) from the Section of Infectious Diseases
reviewed the records while unaware of the results of the urine tests. He determined
whether the patient had an infectious disease, the admission had been delayed
for 7 or more days before coming to the ED, and the presumed diagnosis on
admission was incorrect or masked because of obscure signs or symptoms (eg,
absence of fever, leukocytosis, or localized signs of infection). The analysis
was conducted on a case-by-case study without preset definitions. The evaluation
was based on chart review of the clinical, laboratory, and radiological findings
and the discharge diagnosis. The information was coded and kept confidential.
The hospital's institution review board did not require review of protocols
or informed consent for the urine tests or medical chart review. The investigators
complied with the principles outlined in the Declaration of Helsinki.
DETERMINATION OF AAU
The urine specimens were immediately refrigerated and frozen within
24 hours. Assays for AAU were performed within 1 week with strains of B stearothermophilus ATCC 7953, E coli ATCC 25922, and S pyogenes ATCC 19165 (American
Type Culture Collection, Manassas, Va), as previously described.15
The presence of a zone of inhibition of at least 10 mm with any of the 3 assay
strains was considered evidence of receipt of antimicrobial drugs within the
previous 48 hours.
STATISTICAL ANALYSIS
The data were entered into a commercially available computer program
(Microsoft Excel; Microsoft Corp, Redmond, Wash) and analyzed by means of
statistical software (Epi Info Version 6; Centers for Disease Control and
Prevention, Atlanta, Ga) using the 2 method (Mantel-Haenszel)
and relative risk with 95% confidence intervals.
RESULTS
CHARACTERISTICS OF THE STUDY POPULATION
Four hundred forty-four of the 1182 patients who were seen in the ED
met the criteria for entry into the study (Figure 1). The age and sex distribution of patients with infection
(n = 217; mean [±SD] age, 55 ± 21 years; range, 1-90 years;
male-female ratio, 1.2:1) was not significantly different from those without
infection (n = 227; mean [±SD] age, 51 ± 21 years; range, 1-85
years; male/female ratio, 1.1:1). We detected AAU in 220 of the 444 patients
(49.5%). There was no significant difference in the proportion with AAU in
patients with (53.0%) and without (46.3%) an infection (P = .41) (Figure 1 and Table 1).
|
|
|
|
Flow diagram showing how the patients were selected to enter the
study. ED indicates emergency department.
|
|
|
|
|
|
|
Effect of Recent Antibiotic Use on Delayed Admission or Masked or Missed
Diagnosis*
|
|
|
ILLUSTRATIVE CASES
The following cases illustrate the decision process that was used for
classification. The reviewer was unaware of the results of the urine tests.
Category 1
Infection (+), urine test (+), delayed admission (+), and masked diagnosis (+).
A 2-year-old boy was seen in the ED because of fever for 1 week, vomiting
for 1 day, and shortness of breath. An outside clinic considered him to have
bronchiolitis and treated him with unknown drugs. He improved temporarily,
but dyspnea developed. The final diagnosis was bronchopneumonia and acute
otitis media.
Results of testing for AAU were postive. It appears that this child
was given antibiotics without supporting information from results of an adequate
physical examination, a chest x-ray film, or laboratory tests, leading to
delayed admission and masked diagnosis.
Category 2
Infection (+), urine test (+), delayed admission (-), and masked diagnosis (+).
A 77-year-old man sought medical care at a local hospital because of
3 days of generalized abdominal pain and 4 days of constipation. He was thought
to have gastritis or peptic ulcer disease and was treated with unknown drugs.
Symptoms recurred after initial improvement. When seen in the ED, he was found
to have an acute abdomen and underwent a laparotomy. The final diagnosis was
perforated gastric ulcer with peritonitis.
Results of testing for AAU were positive. It is unclear why this man
was treated with antibiotics for apparent gastritis or peptic ulcer disease,
masking the final diagnosis. Although the admission was delayed, it did not
meet the preset criterion of 7 or more days.
Category 3
Infection (+), urine test (+), delayed admission (+), and masked diagnosis (-).
A 58-year-old woman noted anal pain and fever for 1 week. She sought
advice from several physicians for a presumed inflamed hemorrhoid. She was
treated with oral and injected drugs but did not improve. She came to the
ED and was immediately admitted. A computed tomographic (CT) scan demonstrated
an ischiorectal abscess. She underwent fistulostomy and fasciotomy and recovered.
The culture of the abscess yielded E coli susceptible
to all tested antibiotics.
Results of testing for AAU were positive. It appears that her physicians
did not perform an adequate rectal examination. Antibiotics had been given
because of fever, leading to delayed admission. The diagnosis was readily
made in the ED.
Category 4
Infection (+), urine test (-), delayed admission (-), and masked diagnosis (+).
A 32-year-old man noted generalized discomfort and fever for 5 days.
He came directly to the ED because of worsening of symptoms. He was thought
to have spondylolisthesis at the space between L4 and L5 and was admitted.
A CT scan was performed because of persistent pain and fever and disclosed
a paraspinal abscess at L4-5.
The reviewer thought that this patient might have taken antibiotics
that masked the diagnosis. Results of testing for AAU were negative, and he
had not taken antibiotics. Admission was not delayed, but the diagnosis was
delayed until performance of a CT scan.
Category 5
Infection (-), urine
test (+), delayed admission (+), and masked diagnosis (+).
A 71-year-old man was seen at several medical centers because of fever
and weight loss for several months. He was considered to have acute pharyngitis
or a viral infection and was treated with a variety of oral and injected drugs.
His symptoms waxed and waned. Finally, he came to the ED and was admitted
with the tentative diagnosis of fever of unknown origin. The discharge diagnosis
was malignant lymphoma.
Results of testing for AAU were positive. This man had been given antibiotics
for symptomatic treatment of fever and weight loss, without the benefit of
an adequate differential diagnosis and appropriate studies, leading to delayed
admission and missed diagnosis.
Category 6
Infection (-), urine test
(-), delayed admission (+), and masked diagnosis (+).
Persistent right upper quadrant abdominal pain and generalized itching
developed in a 65-year-old man over several weeks. He visited many clinics,
where he was given a variety of drugs for symptomatic pain relief. Finally,
a local physician referred him to the ED for presumed gallstones. On admission,
he was noted to have jaundice and hepatomegaly. The CT scan revealed a carcinoma
at the head of the pancreas with liver metastases.
This man had received a variety of pain medications, which appeared
to delay admission and mask the diagnosis. Antibiotics had not been given
recently, and results of testing for AAU were negative.
Category 7
Infection (-), urine
test (-), delayed admission (+), and masked diagnosis (-).
Severe low back pain developed in a 44-year-old laborer after lifting
a heavy machine about 2 weeks before being seen in the ED. He had purchased
over-the-counter drugs for pain relief. The symptoms waxed and waned but persisted.
He was thought to have severe sciatica and was admitted. Magnetic resonance
imaging revealed a herniated intervertebral disc.
This patient elected to treat himself with pain medications and delayed
seeking medical advice. Results of testing for AAU were negative.
EFFECT OF RECENT ANTIBIOTIC USE ON DELAY OF ADMISSION OR MASKED DIAGNOSIS
The effect of recent antibiotic use on delayed admission or masked diagnosis
among the 444 patients is summarized in Table 1. Patients with infection and AAU were more likely to have
had a delayed admission and a masked diagnosis than those without AAU (P = .03 and P<.001, respectively).
The differences between these groups were 13.2% and 23.2%, respectively. Patients
without infection and with AAU were no more likely to have had a delayed admission
(P = .64), but were more likely to have had a missed
diagnosis (P = .02) than those without AAU. The differences
between these groups were 5.1% and 12.8%, respectively. The relative risks
are shown in Table 1.
A similar analysis was performed using E coli
and S pyogenes without B stearothermophilus as the assay strains. Patients with infection and AAU were more likely
to have had a delayed admission and a masked diagnosis than those without
AAU (P = .14 and P = .005,
respectively). Patients without infection and with AAU were no more likely
to have had a delayed admission (P = .95), but more
likely to have had a masked diagnosis (P = .008)
than those without AAU.
COMMENT
The current study sought to determine whether prior antimicrobial drug
use would delay admission or mask the diagnosis in patients seen at an ED
in Taiwan. It soon became apparent that patients were unaware of the drugs
that were prescribed, purchased, or injected by a local pharmacist. Their
physicians refused to provide information or stated that it was unavailable.
Accordingly, we developed a simple microbiological method to detect AAU and
to provide an independent marker of recent antimicrobial drug use.15
In the current study, we found that use of antimicrobial drugs before
coming to an ED was associated with a significant delay in hospital admission
and masked diagnoses in patients with infection. It was also associated with
a significant increase in missed diagnoses among patients without infection.
The effect of prior antimicrobial drug use appears to be robust in view of
the large number of confounding variables. These include the wide range in
patient age, high rates of antimicrobial drug use, diverse medical and surgical
conditions, and numerous primary care physicians.
The shortcomings of this study include the inability (1) to detect prior
use of antimicrobial drugs for more than 1 or 2 days before arrival in the
ED or drugs that are not excreted in the urine, (2) to determine the outcome
for patients who were discharged from the ED, and (3) to assess the potential
benefits and deficits of antimicrobial therapy among patients who did not
come to the ED. Furthermore, the high frequency of delayed admissions and
masked or missed diagnoses in this population for other reasons could have
partly obscured the effect of prior use of antimicrobial drugs. There is also
the potential for systemic bias that could not be completely addressed in
this report. This bias might occur in patients who suddenly become acutely
ill and did not have time to see a physician or take an antibiotic. These
patients would not be likely to have had positive results of a urine test
or a delayed admission. Patients who had been ill for some time would have
been more likely to seek previous medical attention and to have a delayed
admission.
There is ample evidence of overuse of antimicrobial drugs in outpatient
practices in the United States.17-18
We are unaware of studies dealing with delayed admission and masked or missed
diagnoses, other than anecdotal accounts in case reports and conferences.
Further studies are needed to confirm our findings and to determine the impact
of inappropriate use of antibiotics on morbidity, mortality, and costs.
The reasons why physicians continue to prescribe antibiotics inappropriately
are complex. Some years ago, Kunin et al2 coined
the phrase "drugs of fear" to characterize the compelling need of physicians
to use the latest and best antibiotics to solve a problem and to meet patient
expectations. These fears are compounded each time a trusted drug becomes
less useful because of resistance. The clinical reasoning appears to be quite
straightforward, ie, why not use a reasonably safe and effective broad-spectrum
drug to prevent an unfavorable outcome for a seemingly trivial but potentially
serious illness when the specific diagnosis is not immediately apparent? This
perception helps to explain why the promotion of drugs to physicians and the
public is so successful.
The problem of inappropriate use of antimicrobial drugs may worsen,
despite numerous recommendations and guidelines prepared by eminent organizations
and alarming reports in the news media. We believe that attention needs to
be focused on the constraints of medical practice, patient expectation, and
promotional practices.19 The research questions
are as follows: (1) Would the use of antimicrobial drugs be improved if physicians
spent more time and provided more personalized care to their patients? (2)
Would the ready availability of low-cost, rapid diagnostic tests improve the
situation? (3) Can the public be better informed about the risks and benefits
of antimicrobial drugs? (4) Do current practice guidelines meet the needs
of practicing physicians? (5) Can more effective methods be developed to help
physicians diagnose and manage common infectious diseases? (6) Can government
and nonprofit organizations develop sophisticated methods to counteract exuberant
pharmaceutical marketing?20
AUTHOR INFORMATION
Accepted for publication January 18, 2001.
This work was supported by grant DD01-861X-CR5038, from the National
Health Research Institute, Taipei, Taiwan.
Corresponding author and reprints: Calvin M. Kunin, MD, Department
of Internal Medicine, Ohio State University, Room M110 Starling Loving Hall,
320 W 10th Ave, Columbus, OH 43210 (e-mail: ckunin{at}columbus.rr.com).
From the Sections of Infectious Diseases and Microbiology, Veterans
General Hospital, Kaohsiung, and National Yang-Ming University, Taipei, Taiwan
(Dr Liu, Mr Huang, and Ms Huang); and the Department of Internal Medicine,
Ohio State University, Columbus (Dr Kunin).
REFERENCES
1. Jawetz E. Antimicrobial chemotherapy. Annu Rev Microbiol. 1956;10:85-114.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
2. Kunin CM, Tupasi T, Craig WA. Use of antibiotics: a brief exposition of the problem and some tentative
solutions. Ann Intern Med. 1973;79:555-560.
3. Neu HC. The crisis in antibiotic resistance. Science. 1992;257:1064-1073.
4. US Congress, Office of Technology Assessment. Impacts of Antibiotic-Resistant Bacteria: OTA-H-629. Washington, DC: US Government Printing Office; September 1995.
5. ASM Task Force on Antimicrobial Resistance. Report of the ASM Task Force on Antibiotic Resistance. Washington, DC: American Society for Microbiology; 1995.
6. Schwartz B. Preventing the spread of antimicrobial resistance among respiratory
pathogens in industrialized countries: the case for judicious antimicrobial
use. Clin Infect Dis. 1999;28:211-213.
FREE FULL TEXT
7. Wenzel RP, Kunin CM. Should oral antibiotics be sold over the counter? J Infect Dis. 1994;170:1256-1259.
FREE FULL TEXT
8. Bauchner H, Wise PH. Antibiotics without prescription: "bacterial or medical resistance?" Lancet. 2000;355:1480.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
9. Reeves DS, Finch RG, Bax RP, et al. Working Party report: self-medication of antimicrobials without prescription
(also called "over-the-counter" use). J Antimicrob Chemother. 1999;44:163-177.
FREE FULL TEXT
10. Wood MJ. Over-the-counter antibiotics. J Antimicrob Chemother. 1999;44:149-150.
FREE FULL TEXT
11. Chiou CC, Liu YC, Huang TS, et al. Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan. J Clin Microbiol. 1998;36:1933-1937.
FREE FULL TEXT
12. Hsueh PR, Teng LJ, Lee LN, Yang PC, Ho SW, Luh KT. Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole
resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. J Clin Microbiol. 1999;37:897-901.
FREE FULL TEXT
13. Hsueh PR, Teng LJ, Lee LN, Yang PC, Ho SW, Luh KT. Dissemination of high-level penicillin, extended spectrum cephalosporin
and erythromycin-resistant Streptococcus pneumoniae
clones in Taiwan. J Clin Microbiol. 1999;37:221-224.
FREE FULL TEXT
14. Cheng S-H, Chiang T-L. The effect of universal health insurance on health care utilization
in Taiwan. JAMA. 1997;278:89-93.
FREE FULL TEXT
15. Liu YC, Huang WK, Huang TS, Kunin CM. Detection of antimicrobial activity in urine for epidemiologic studies
of antibiotic use. J Clin Epidemiol. 1999;52:539-545.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
16. Liu YC, Huang WK, Huang TS, Kunin CM. Extent of antibiotic use in Taiwan shown by antimicrobial activity
in urine. Lancet. 1999;354:1360.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
17. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians
in the United States. JAMA. 1995;273:214-219.
FREE FULL TEXT
18. Nyquist A-C, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory infections,
and bronchitis. JAMA. 1998;279:875-877.
FREE FULL TEXT
19. Barden LS, Dowell SF, Schwartz B, Lackey C. Current attitudes regarding use of antimicrobial agents: results from
physicians' and parents' focus group discussions. Clin Pediatr (Phila). 1998;37:665-672.
FREE FULL TEXT
20. Angell M. The pharmaceutical industry: to whom is it accountable [editorial]? N Engl J Med. 2000;342:1902-1904.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The Inventory of Antibiotics in Russian Home Medicine Cabinets
Stratchounski et al.
Clinical Infectious Diseases 2003;37:498-505.
ABSTRACT
| FULL TEXT
Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients
Fagon and Chastre
Eur Respir J 2003;22:77s-83s.
ABSTRACT
| FULL TEXT
Empiric Treatment of Community-Acquired Pneumonia with Fluoroquinolones, and Delays in the Treatment of Tuberculosis
Dooley et al.
Clinical Infectious Diseases 2002;34:1607-1612.
ABSTRACT
| FULL TEXT
Ventilator-associated Pneumonia
Chastre and Fagon
Am. J. Respir. Crit. Care Med. 2002;165:867-903.
ABSTRACT
| FULL TEXT
|